Gore Joins Vascular and Endovascular Leaders in Recognizing the 2014 Pioneers in Performance for North America
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
Gore Launches Unique Biomaterial for Complex Ventral Hernia Repair
Gore to launch its new hybrid device, GORE® SYNECOR Biomaterial, at the 17th Annual Hernia Repair Conference in Washington, D.C.
Nominees Announced for 2013-2014 Pioneers in Performance Awards for Europe; Online Voting Opens at PioneersInPerformance.com
Charing Cross International Symposium
GORE® EXCLUDER® Iliac Branch Endoprosthesis Approved in Japan
Gore designed All-in-One System to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms
New Technology Add-On Payment Awarded for GORE® EXCLUDER® Iliac Branch Endoprosthesis
Recognition of new technology status will provide additional hospital reimbursement for IBE when used in FDA approved indications
Gore Launches Clinical Quality Improvement (CQI) Project of New Hernia Repair Device
New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial
Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
GORE Device Outperforms Standard Treatment Option for Stenoses or Thrombotic Occlusions
First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study
Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population
Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE® VIABAHN® Endoprosthesis
Innovative treatment offers long-term solution for ISR
Gore Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis
Longest stent-graft introduced in the United States